A New Model for Preventing Life-Threatening Blood Clots
The Bio Report
00:00
Cancer Associated Trombosis - What's the Trial Design?
We're looking for both acy and safety. In those studies, there's a broad set of patients who can benefit from anti coagulance. We think people would get treated more effectively an for longer am to give em that protection if somebody developed an fda approve drug. The two studies combined are over two thousand, 200 patients. And obviously the end point is is resolute resolution of the clot in comparison with the the comparator.
Transcript
Play full episode
